Cargando…

Molecular pathways in idiopathic pulmonary fibrosis pathogenesis: Transcending barriers to optimally targeted pharmacotherapies

Detalles Bibliográficos
Autores principales: Strykowski, Rachel, Adegunsoye, Ayodeji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114113/
https://www.ncbi.nlm.nih.gov/pubmed/33965873
http://dx.doi.org/10.1016/j.ebiom.2021.103373
_version_ 1783690997832613888
author Strykowski, Rachel
Adegunsoye, Ayodeji
author_facet Strykowski, Rachel
Adegunsoye, Ayodeji
author_sort Strykowski, Rachel
collection PubMed
description
format Online
Article
Text
id pubmed-8114113
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-81141132021-05-18 Molecular pathways in idiopathic pulmonary fibrosis pathogenesis: Transcending barriers to optimally targeted pharmacotherapies Strykowski, Rachel Adegunsoye, Ayodeji EBioMedicine Editorial Elsevier 2021-05-06 /pmc/articles/PMC8114113/ /pubmed/33965873 http://dx.doi.org/10.1016/j.ebiom.2021.103373 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Editorial
Strykowski, Rachel
Adegunsoye, Ayodeji
Molecular pathways in idiopathic pulmonary fibrosis pathogenesis: Transcending barriers to optimally targeted pharmacotherapies
title Molecular pathways in idiopathic pulmonary fibrosis pathogenesis: Transcending barriers to optimally targeted pharmacotherapies
title_full Molecular pathways in idiopathic pulmonary fibrosis pathogenesis: Transcending barriers to optimally targeted pharmacotherapies
title_fullStr Molecular pathways in idiopathic pulmonary fibrosis pathogenesis: Transcending barriers to optimally targeted pharmacotherapies
title_full_unstemmed Molecular pathways in idiopathic pulmonary fibrosis pathogenesis: Transcending barriers to optimally targeted pharmacotherapies
title_short Molecular pathways in idiopathic pulmonary fibrosis pathogenesis: Transcending barriers to optimally targeted pharmacotherapies
title_sort molecular pathways in idiopathic pulmonary fibrosis pathogenesis: transcending barriers to optimally targeted pharmacotherapies
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114113/
https://www.ncbi.nlm.nih.gov/pubmed/33965873
http://dx.doi.org/10.1016/j.ebiom.2021.103373
work_keys_str_mv AT strykowskirachel molecularpathwaysinidiopathicpulmonaryfibrosispathogenesistranscendingbarrierstooptimallytargetedpharmacotherapies
AT adegunsoyeayodeji molecularpathwaysinidiopathicpulmonaryfibrosispathogenesistranscendingbarrierstooptimallytargetedpharmacotherapies